Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Risankizumab
(Synonym: Risankizumab (genetical recombination) (JAN))
1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬4件: 37, 96, 97, 271
2Risankizumab (Genetical Recombination)1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 97
3Risankizumab 10 mg/ml
(Synonym: Risankizumab (genetical recombination) (JAN))
1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96
4Risankizumab 180 mg SC
(Synonym: Risankizumab (genetical recombination) (JAN))
1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96
5Risankizumab 600 mg IV
(Synonym: Risankizumab (genetical recombination) (JAN))
1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96
6Risankizumab 90 mg/ml
(Synonym: Risankizumab (genetical recombination) (JAN))
1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96
7Risankizumab IV
(Synonym: Risankizumab (genetical recombination) (JAN))
1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97
8Risankizumab On-Body Injector (OBI)
(Synonym: Risankizumab (genetical recombination) (JAN))
1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96
9Risankizumab SC
(Synonym: Risankizumab (genetical recombination) (JAN))
1件: Risankizumab1件: D11052 (Name: Risankizumab (genetical recombination) (JAN))1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97